Mirati Hoping to Set Apart Adagrasib in Competitive KRAS-Mutant NSCLC Market With CNS Activity Data

Press/Media

Period	Jun 7 2022

Media coverage

Title	Mirati Hoping to Set Apart Adagrasib in Competitive KRAS-Mutant NSCLC Market With CNS Activity Data
Media name/outlet	Precision Oncology News
Country/Territory	United States
Date	06/7/22
URL	https://www.precisiononcologynews.com/cancer/mirati-hoping-set-apart-adagrasib-competitive-kras-mutant-nsclc-market-cns-activity-data
Persons	Sukhmani Kaur Padda